Description
Classification
6x CB Labs MOTS-c 40mg x 3ml is a bulk product specification for a preparation marketed as containing MOTS-c, a mitochondrial-derived peptide.
MOTS-c, short for mitochondrial open reading frame of the 12S rRNA-c, is a 16-amino-acid peptide that has been investigated in relation to cellular metabolism, insulin sensitivity and metabolic homeostasis.
MOTS-c remains an investigational compound rather than an established UK-authorised medicine. FDA review materials report a lack of human clinical safety and exposure data for administered MOTS-c-related products.
The stated quantity is 6 units, with each unit described as containing 40mg in 3ml, giving a stated total of 240mg across six units.
What is 6x CB Labs MOTS-c 40mg x 3ml?
MOTS-c is a peptide encoded within mitochondrial DNA and is being studied as a potential regulator of metabolic processes.
Preclinical research has explored its relationship with energy metabolism, insulin sensitivity, AMPK signalling and cellular stress responses. A Phase 2a human study is currently investigating whether MOTS-c may improve insulin sensitivity in adults with prediabetes and overweight or obesity.
The stated 40mg x 3ml specification describes the claimed quantity and volume of each unit. It should not be interpreted as a clinically validated dose.
Dosage
There is currently no established UK-authorised dosage for the specific CB Labs MOTS-c 40mg x 3ml product.
The ongoing Phase 2a study is investigating an experimental MOTS-c regimen under controlled clinical-trial conditions. Research dosing should not be presented as instructions for using an independently marketed product.
The stated 40mg is therefore a product specification rather than a recommended individual dose.
How Does MOTS-c Work?
MOTS-c is being investigated as a mitochondrial-derived signalling peptide.
Preclinical research suggests possible involvement in pathways associated with:
- Cellular energy metabolism.
- Insulin sensitivity.
- AMPK signalling.
- Metabolic homeostasis.
- Cellular responses to metabolic stress.
However, the precise mechanism of administered MOTS-c in humans has not been established. FDA materials specifically note the lack of human data needed to assess its safety.
Potential Benefits Under Investigation
Research has investigated MOTS-c for potential effects involving:
- Insulin sensitivity.
- Glucose metabolism.
- Metabolic homeostasis.
- Energy regulation.
- Exercise-related metabolic responses.
- Age-related metabolic changes.
These remain research outcomes rather than established clinical benefits. The current Phase 2a trial is specifically designed to investigate insulin sensitivity and related metabolic markers in adults with prediabetes and overweight/obesity.
When Should You Not Use MOTS-c 40mg?
Because MOTS-c is investigational, there is no UK-authorised patient prescribing framework for this specific 40mg x 3ml product.
Particular caution is warranted where:
- The active ingredient cannot be independently verified.
- The manufacturer or batch information is unavailable.
- The concentration cannot be confirmed.
- Sterility cannot be established for an injectable preparation.
- The product’s regulatory status is unclear.
- Appropriate pharmaceutical quality documentation is unavailable.
FDA review materials identify significant gaps in safety and human exposure information for MOTS-c-related products.
What is the Mechanism of MOTS-c 40mg?
MOTS-c is being investigated as a mitochondrial-derived peptide involved in metabolic signalling.
Experimental research has associated MOTS-c with AMPK-related pathways, which are important in cellular energy sensing and metabolic regulation. These findings are primarily derived from laboratory and preclinical research.
The mechanism and clinical significance of administered MOTS-c in humans remain under investigation.
Uses of CB Labs MOTS-c 40mg x 3ml
MOTS-c is currently being investigated in areas including:
- Insulin sensitivity.
- Prediabetes.
- Overweight and obesity.
- Metabolic homeostasis.
- Mitochondrial function.
- Exercise and metabolic research.
A current Phase 2a study is examining MOTS-c in adults with prediabetes and overweight/obesity, with insulin sensitivity as a primary efficacy focus.
These are research areas rather than authorised UK indications.
Warnings and Precautions
The stated 40mg x 3ml specification does not itself establish pharmaceutical identity, purity, potency, sterility or clinical safety.
For a research preparation, relevant documentation should, where applicable, identify:
- Exact active ingredient.
- Quantity and concentration.
- Manufacturer.
- Batch or lot number.
- Certificate of analysis.
- Identity and purity testing.
- Expiry information.
- Storage requirements.
- Sterility and endotoxin testing where relevant.
- Regulatory status.
FDA materials highlight potential concerns including immunogenicity and peptide-related impurities and state that important human safety information is lacking.
Side Effects of MOTS-c 40mg
The safety profile of administered MOTS-c in humans has not yet been adequately established.
The ongoing Phase 2a study includes monitoring of adverse events, vital signs, ECGs and laboratory testing as part of its safety assessment.
Consequently, a specific commercial product should not be presented as having an established side-effect profile based solely on laboratory or animal research.
Storage for CB Labs MOTS-c 40mg x 3ml
Storage requirements should be obtained from verified documentation for the exact product and formulation.
Check the manufacturer’s instructions for:
- Recommended temperature.
- Refrigeration requirements.
- Protection from light.
- Freezing restrictions.
- Transport conditions.
- Expiry date.
- Handling requirements after opening.
Storage instructions for another peptide product should not automatically be applied to MOTS-c.
Where to Buy 6x CB Labs MOTS-c 40mg x 3ml?
To get 6x CB Labs MOTS-c 40mg x 3ml online, go to Steroid Sanctuary today to get the best deal on this medicine.
Frequently Asked Questions
1. What is 6x CB Labs MOTS-c 40mg x 3ml?
It is a bulk product specification describing 6 units, with each unit stated to contain 40mg of MOTS-c in 3ml.
2. What is MOTS-c?
MOTS-c is a mitochondrial-derived peptide being investigated for its potential role in metabolic signalling, insulin sensitivity and cellular energy regulation.
3. Is MOTS-c approved as a medicine?
MOTS-c remains investigational. FDA materials report a lack of human clinical safety and exposure data for administered MOTS-c-related products.
4. What does 40mg x 3ml mean?
It describes the stated quantity and volume of each unit: 40mg in 3ml. Six units represent a stated total of 240mg.
5. Is 40mg a recommended dose?
No. 40mg is the stated product specification, not a validated human dosing recommendation. Human research is still evaluating MOTS-c under controlled clinical-trial conditions.





Reviews
There are no reviews yet.